ArticleZeitschrift fur Rheumatologie2024

Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis.

Young Ho Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.